Trustmark National Bank Trust Department Amgen Inc Transaction History

Trustmark National Bank Trust Department

$1.32 Billion
Q3 2024

A detailed history of Trustmark National Bank Trust Department transactions in Amgen Inc stock. As of the latest transaction made, Trustmark National Bank Trust Department holds 25,944 shares of AMGN stock, worth $7.47 Million. This represents 0.63% of its overall portfolio holdings.

Number of Shares

25,944

Previous 30,393 14.64%

Holding current value

$7.47 Million

Previous $9.5 Million 11.97%

% of portfolio

0.63%

Previous 0.76%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 08, 2024	SELL	$309.38 - $337.38 $1.38 Million - $1.5 Million	-4,449 Reduced 14.64%	25,944 $8.36 Million
Q2 2024 Aug 14, 2024	SELL	$262.75 - $319.31 $213,090 - $258,960	-811 Reduced 2.6%	30,393 $9.5 Million
Q1 2024 May 10, 2024	BUY	$268.87 - $324.56 $513,272 - $619,585	1,909 Added 6.52%	31,204 $8.87 Million
Q4 2023 Feb 14, 2024	SELL	$255.7 - $288.46 $54,208 - $61,153	-212 Reduced 0.72%	29,295 $8.44 Million
Q3 2023 Nov 13, 2023	BUY	$218.65 - $271.46 $279,653 - $347,197	1,279 Added 4.53%	29,507 $7.93 Million
Q2 2023 Aug 10, 2023	SELL	$214.27 - $253.37 $102,206 - $120,857	-477 Reduced 1.66%	28,228 $6.27 Million
Q1 2023 May 10, 2023	SELL	$225.79 - $275.2 $60,737 - $74,028	-269 Reduced 0.93%	28,705 $6.94 Million
Q4 2022 Feb 14, 2023	SELL	$229.03 - $291.01 $44,660 - $56,746	-195 Reduced 0.67%	28,974 $7.61 Million
Q3 2022 Nov 09, 2022	SELL	$224.46 - $253.15 $222,664 - $251,124	-992 Reduced 3.29%	29,169 $6.58 Million
Q2 2022 Aug 11, 2022	BUY	$230.71 - $256.74 $135,888 - $151,219	589 Added 1.99%	30,161 $7.34 Million
Q1 2022 May 12, 2022	BUY	$219.27 - $242.57 $118,405 - $130,987	540 Added 1.86%	29,572 $7.15 Million
Q4 2021 Feb 11, 2022	SELL	$198.88 - $227.6 $122,112 - $139,746	-614 Reduced 2.07%	29,032 $6.53 Million
Q3 2021 Nov 12, 2021	BUY	$212.27 - $248.7 $706,010 - $827,176	3,326 Added 12.64%	29,646 $6.3 Million
Q2 2021 Aug 11, 2021	BUY	$233.58 - $259.14 $268,617 - $298,011	1,150 Added 4.57%	26,320 $6.42 Million
Q1 2021 May 14, 2021	SELL	$221.91 - $258.6 $305,791 - $356,350	-1,378 Reduced 5.19%	25,170 $6.26 Million
Q4 2020 Feb 16, 2021	BUY	$216.38 - $257.67 $281,726 - $335,486	1,302 Added 5.16%	26,548 $6.1 Million
Q3 2020 Nov 13, 2020	BUY	$234.65 - $260.95 $165,193 - $183,708	704 Added 2.87%	25,246 $6.42 Million
Q2 2020 Aug 12, 2020	BUY	$197.81 - $242.74 $4,549 - $5,583	23 Added 0.09%	24,542 $5.79 Million
Q1 2020 May 14, 2020	BUY	$182.24 - $241.7 $68,157 - $90,395	374 Added 1.55%	24,519 $4.97 Million
Q4 2019 Feb 14, 2020	SELL	$189.21 - $243.2 $67,169 - $86,336	-355 Reduced 1.45%	24,145 $5.82 Million
Q3 2019 Nov 14, 2019	BUY	$174.11 - $208.62 $110,908 - $132,890	637 Added 2.67%	24,500 $4.74 Million
Q2 2019 Aug 13, 2019	BUY	$166.7 - $195.41 $236,213 - $276,895	1,417 Added 6.31%	23,863 $4.4 Million
Q1 2019 May 13, 2019	SELL	$180.87 - $203.88 $6,330 - $7,135	-35 Reduced 0.16%	22,446 $4.26 Million
Q4 2018 Feb 14, 2019	BUY	$178.4 - $208.25 $85,453 - $99,751	479 Added 2.18%	22,481 $4.38 Million
Q3 2018 Feb 22, 2019	SELL	$185.29 - $208.89 $1.18 Million - $1.33 Million	-6,366 Reduced 22.44%	22,002 $4.56 Million
Q3 2018 Nov 14, 2018	BUY	$185.29 - $208.89 $1.18 Million - $1.34 Million	6,393 Added 29.09%	28,368 $5.88 Million
Q2 2018 Aug 14, 2018	SELL	$166.05 - $186.51 $272,986 - $306,622	-1,644 Reduced 6.96%	21,975 $4.06 Million
Q1 2018 May 15, 2018	BUY	$169.43 - $198.0 $323,611 - $378,180	1,910 Added 8.8%	23,619 $4.03 Million
Q4 2017 Feb 14, 2018	BUY	$168.79 - $188.59 $335,892 - $375,294	1,990 Added 10.09%	21,709 $3.77 Million
Q3 2017 Nov 09, 2017	BUY	$167.29 - $191.0 $3.3 Million - $3.77 Million	19,719	19,719 $3.68 Million

Others Institutions Holding AMGN

# of Institutions

3,121

Shares Held

410M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $154B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Trustmark National Bank Trust Department, based on Form 13F filings with the SEC.

News

Stay updated on Trustmark National Bank Trust Department with notifications on news.

Account

Trustmark National Bank Trust Department Amgen Inc Transaction History